Drugs / Cholvax
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02742558 | Apr 2016 → Jun 2017 | cholera | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07685574 | Sep 2024 → Sep 2029 expected | cholera | International Centre for Diarrhoeal Disease Research, Bangladesh | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cholvax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07685574 ↗ |
| Modality | Vaccine | “Cholvax is locally produced orally administered whole cell inactivated bivalent cholera vaccine.” NCT02742558 ↗ |
| Route | Oral | “Cholvax is locally produced orally administered whole cell inactivated bivalent cholera vaccine.” NCT02742558 ↗ |